Crystalline microporous material mediated conversion of C1-3 oxygenate compounds to C4 oxygenate compounds

US11034713B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11034713-B2
Application numberUS-201515319332-A
CountryUS
Kind codeB2
Filing dateJun 18, 2015
Priority dateJun 19, 2014
Publication dateJun 15, 2021
Grant dateJun 15, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A process for the preparation of C4 oxygenate compounds such as threose, erythrose or erythrulose starting from a composition comprising C1-3 oxygenate compounds such as formaldehyde, glycolaldehyde, glyoxal, pyruvaldehyde or acetol, wherein the process is carried out in the presence of a crystalline microporous material having a ring pore structure selected from an eight-membered ring pore structure or a ten-membered ring pore structure.

First claim

Opening claim text (preview).

The invention claimed is: 1. A process for the preparation of one or more C 4 oxygenate compounds of the formula C 4 H 8 O 4 from a composition comprising C 1-3 oxygenate compounds, the C 4 oxygenate compounds selected from one or more of the group consisting of threose, erythrose and erythrulose, wherein the composition comprising C 1-3 oxygenate compounds comprises glycolaldehyde and wherein the C 4 oxygenates are selectively formed from glycolaldehyde in the presence of a solvent and a crystalline microporous material comprising a zeotype material comprising a metal selected from one or more of the group consisting of zirconium, aluminum, tin or titanium and having a structure selected from the group consisting of CHA, LTA, MFI, MEL, MTT, MWW, TON, HEU, AEL, AFO, and FER, wherein the C 4 oxygenate compounds do not further react to form oxygenate compounds with a greater number of carbon atoms. 2. The process according to claim 1 , wherein the composition comprising C 1-3 oxygenate compounds further comprises one or more compounds selected from the group consisting of formaldehyde, glyoxal, pyruvaldehyde and acetol. 3. The process according to claim 2 , wherein the composition comprising C 1-3 oxygenate compounds comprises glycolaldehyde at a concentration of at least 5 wt %. 4. The process according to claim 1 , wherein the solvent is selected from one or more of the groups consisting of water, alcohol and a water and alcohol mixture. 5. The process according to claim 4 , wherein the alcohol is selected from one or more of the group consisting of methanol and ethanol. 6. The process according to claim 1 , wherein the crystalline microporous material comprises from 0.1 wt % to 15 wt % of the metal. 7. The process according to claim 1 , wherein the process is carried out at a temperature between 25° C. and 150° C. 8. The process according to claim 1 , further comprising the step of hydrogenating the C 4 oxygenate compounds. 9. The process according to claim 1 , wherein the process is a one-step process. 10. The process according to claim 1 , further comprising the steps of isomerizing and esterifying the C 4 oxygenate compounds in the presence of Sn zeolite beta (Sn-BEA). 11. The process according to claim 1 , further comprising the step of converting the C 4 oxygenate compounds to one or more compounds selected from the group consisting of erythritol and threitol. 12. The process according to claim 1 , wherein a prior step is performed of pyrolyzing biomass or one or more oxygenate compounds selected from the group consisting of fructose, glucose, sucrose, xylose or isomers thereof, to produce a composition comprising the C 1-3 oxygenate compounds.

Assignees

Inventors

Classifications

  • Silicoaluminophosphates [SAPO compounds] · CPC title

  • in framework positions · CPC title

  • Silicates, aluminosilicates or borosilicates of titanium, zirconium or hafnium {(B01J29/005 takes precedence)} · CPC title

  • Other types characterised by their X-ray diffraction pattern and their defined composition {(C01B39/023, C01B39/026, C01B39/06 take precedence)} · CPC title

  • using at least one organic template directing agent · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11034713B2 cover?
A process for the preparation of C4 oxygenate compounds such as threose, erythrose or erythrulose starting from a composition comprising C1-3 oxygenate compounds such as formaldehyde, glycolaldehyde, glyoxal, pyruvaldehyde or acetol, wherein the process is carried out in the presence of a crystalline microporous material having a ring pore structure selected from an eight-membered ring pore str…
Who is the assignee on this patent?
Haldor Topsoe As
What technology area does this patent fall under?
Primary CPC classification C07H1/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).